GSK To Cut $1.5 Billion In Restructuring Initiative As Avandia Q3 Sales Plummet
This article was originally published in The Pink Sheet Daily
Executive Summary
U.S. Avandia sales fall 48 percent to $266 million; overall pharmaceutical sales were down 2 percent to $9.4 billion.
You may also be interested in...
GSK Acts On Cost Plan, Cuts Research Jobs
U.K. firm’s busy spring includes internal downsizing, external investments.
GSK Acts On Cost Plan, Cuts Research Jobs
U.K. firm’s busy spring includes internal downsizing, external investments.
GSK Pharma Operations Head Stout To Leave In February
U.S. Pharmaceuticals President Viehbacher, who competed with Stout to replace CEO Garnier, to stay and join board of directors.